869856-07-5 Usage
General Description
(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-methanamine is a chemical compound that is a derivative of the bicyclo[4.2.0]octadiene ring system and contains an amino group. It has a stereochemistry designated as (7S), indicating the position of the substituents on the ring. The compound features two methoxy (CH3O) groups and a methanamine (CH3NH2) group attached to the ring structure. This chemical may have potential applications in the field of organic synthesis, medicinal chemistry, or pharmacology, where compounds with bicyclic ring systems and amine functionalities are of interest. Further research and testing would be necessary to determine the specific properties and potential uses of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 869856-07-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,8,5 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 869856-07:
(8*8)+(7*6)+(6*9)+(5*8)+(4*5)+(3*6)+(2*0)+(1*7)=245
245 % 10 = 5
So 869856-07-5 is a valid CAS Registry Number.
869856-07-5Relevant articles and documents
Exploiting the Biocatalytic Toolbox for the Asymmetric Synthesis of the Heart-Rate Reducing Agent Ivabradine
Pedragosa-Moreau, Sandrine,Le Flohic, Alexandre,Thienpondt, Vivien,Lefoulon, Fran?ois,Petit, Anne-Marie,Ríos-Lombardía, Nicolás,Morís, Francisco,González-Sabín, Javier
, p. 485 - 493 (2017/02/10)
Several chemoenzymatic routes have been evaluated for the production of the heart-rate reducing agent ivabradine. Lipases and ω-transaminases have been identified as useful biocatalysts for the preparation of key enantiopure precursors. The lipase-catalysed kinetic resolution by alkoxycarbonylation of a racemic primary amine and subsequent chemical reduction of the resulting carbamate provided an N-methylated (S)-amine, one step away from ivabradine. Alternatively, the dynamic kinetic resolution by asymmetric bioamination of an aldehyde precursor enabled, in a four-step sequence, the preparative scale synthesis of enantiopure ivabradine in 50% overall yield. (Figure presented.).
